CDT Equity Inc. (CDT)
NASDAQ
Healthcare
Biotechnology
$3.12
▲ +5.28%
Market Cap
$1.5M
Sector
Healthcare
Industry
Biotechnology
Beta
1.49
52-Wk Range
2.53-3700
CEO
Andrew Regan
Country
US
Currency
USD
CDT Equity Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Naples, FL, US. The stock last traded at $3.12, up 5.28% on the session, giving a market capitalisation of $1.5M. On trailing twelve-month figures it carries a trailing P/E of 0.04, a net margin of 6.3%. Its beta of 1.49 implies it has historically moved more than the broad market.
Valuation & profitability (TTM)
P/E
0.04
Price / Sales
0.00
Price / Book
0.09
EV / EBITDA
4.00
Gross margin
38.7%
Operating margin
11.6%
Net margin
6.3%
Return on equity
—
Debt / equity
0.95
Current ratio
2.14
Dividend yield
0.0%
Payout ratio
6.5%
Company profile
Exchange
NASDAQ Global Market
Employees
4
IPO date
2022-03-28
Headquarters
Naples, FL, US
About CDT Equity Inc.
Based in Naples, Florida, CDT Equity, Inc. commenced operations in October 2021. This firm, co-founded by David Joszef Tapolczay and Freda C. Lewis-Hall, focuses on aiding the advancement and market entry of clinical-stage medical innovations.
Comparable companies
CDT Equity Inc. is most often compared with the following Healthcare names:
More research on CDT
Open full interactive analysis & DCF →